Molecular and Conformational Determinants of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) for Activation of the PAC1 Receptor
- 4 May 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (10) , 3308-3316
Abstract
PAC1 receptor is abundant in the CNS and plays an important role in neuronal survival. To identify the molecular determinants and the conformational components responsible for the activation of the PAC1 receptor, we performed a SAR study focusing on the N-terminal domain of its endogenous ligand, PACAP. This approach revealed that residues Asp3 and Phe6 are key elements of the pharmacophore of the PAC1 receptor. This study, supported by NMR structural analyses, suggests that the N-terminal tail of PACAP (residues 1 to 4) adopts a specific conformation similar to a turn when it activates the PAC1 receptor. Moreover, the integrity of the α-helix conformation observed at positions 5 to 7 appears crucial to allow the binding of PACAP. Characterization of analogues led to the identification of several superagonists, such as [Bip6]PACAP27, and of a new potent PAC1 receptor antagonist, [Sar4]PACAP38. The bioactive conformation inferred from this SAR study could constitute an appropriate molecular scaffold supporting the design of nonpeptidic PAC1 receptor agonists.Keywords
This publication has 38 references indexed in Scilit:
- PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: Involvement of the mitochondrial apoptotic pathwayNeurobiology of Disease, 2008
- Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RSProceedings of the National Academy of Sciences, 2007
- Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6Proceedings of the National Academy of Sciences, 2006
- Identification of the Key Residue of Calcitonin Gene Related Peptide (CGRP) 27−37 to Obtain Antagonists with Picomolar Affinity at the CGRP ReceptorJournal of Medicinal Chemistry, 2005
- Calculation of Protein Structures with Ambiguous Distance Restraints. Automated Assignment of Ambiguous NOE Crosspeaks and Disulphide ConnectivitiesJournal of Molecular Biology, 1995
- Solution structure of pituitary adenylate cyclase activating polypeptide by nuclear magnetic resonance spectroscopyBiochemistry, 1993
- Structural requirements for the occupancy of pituitary adenylate‐cyclase‐activating‐peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB‐OK‐1 cell membranesEuropean Journal of Biochemistry, 1992
- Analysis and prediction of the different types of β-turn in proteinsJournal of Molecular Biology, 1988
- CD‐n.m.r. study of the solution conformation of bradykinin analogs containing α‐aminoisobutyric acidInternational Journal of Peptide and Protein Research, 1987
- Prediction of protein conformationBiochemistry, 1974